AKSO HEALTH GR. (SPADR)/3 Cash Flow Reinvestment Rate

Latest as of March 2025: 0.13x

AKSO HEALTH GR. (SPADR)/3 cash flow reinvestment rate. AKSO HEALTH GR. (SPADR)/3 (8HX) has a Cash Flow Reinvestment Rate of 0.13x as of March 2025, reinvesting €154.46K (capex €154.46K ) from operating cash flow of €1.18 Million. See AKSO HEALTH GR. (SPADR)/3 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.13x
(Capex + Investments) / Operating CF

Total Reinvested

€154.46K
Capex + Investments

Operating Cash Flow

€1.18 Million
EUR

Capital Expenditures

€154.46K
EUR

Cash Flow Reinvestment Rate of AKSO HEALTH GR. (SPADR)/3 (2024–2025)

Cash flow reinvestment rate of AKSO HEALTH GR. (SPADR)/3 from 2024 to 2025. Historical reinvestment intensity for AKSO HEALTH GR. (SPADR)/3 across 2 annual periods. Explore AKSO HEALTH GR. (SPADR)/3 debt service capacity to assess how comfortably operating cash covers total debt obligations.

AKSO HEALTH GR. (SPADR)/3 Cash Flow Reinvestment Rate by Year (2024–2025)

AKSO HEALTH GR. (SPADR)/3 cash flow reinvestment rate by year from 2024 to 2025. Year-by-year capital reinvestment analysis for AKSO HEALTH GR. (SPADR)/3. For the full cash flow conversion analysis, see cash flow conversion of AKSO HEALTH GR. (SPADR)/3.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.13x €154.46K €1.18 Million €154.46K —
2024 0.00x €0.00 €1.35 Million €0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow